A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel plus a Reduced Dose ofCapecitabine versus Capecitabine Alone in Patients with HER2 Negative, Hormone Receptor Positive,Locally Advanced or Metastatic Breast Cancer Previously Treated
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Keyphrases
Pharmacology, Toxicology and Pharmaceutical Science